Vaccine Info

Afluria Quadrivalent Influenza Vaccine

Afluria Quadrivalent Influenza Vaccine Description

Afluria Quadrivalent is an inactivated egg-based influenza vaccine that is designed to protect against four different flu viruses, including two influenza A viruses and two influenza B viruses.

For 2020-2021, quadrivalent (four-component) egg-based vaccines are recommended to contain:

  • A/Guangdong-Maonan/SWL1536/2019 (H1N1)pdm09-like virus (updated)
  • A/Hong Kong/2671/2019 (H3N2)-like virus (updated)
  • B/Washington/02/2019 (B/Victoria lineage)-like virus (updated)
  • B/Phuket/3073/2013-like (Yamagata lineage) virus

Afluria Quadrivalent Influenza Vaccine Indication

Afluria Quadrivalent is indicated in people 6 months of age and older, for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.

Afluria Quadrivalent Influenza Vaccine Dosage

Afluria is administered as an intramuscular injection by needle and syringe (6 months and older) or by PharmaJet®Stratis® Needle-Free Injection System (18 through 64 years).

Afluria Quadrivalent Influenza Vaccine News

July 30, 2020  - Seqirus Begins Shipping 2020/21 Influenza Vaccines to the U.S. Market